These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8081009)
1. Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL? Polliack A; Dann EJ Blood; 1994 Sep; 84(6):2057-8. PubMed ID: 8081009 [No Abstract] [Full Text] [Related]
2. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. Piro LD; Carrera CJ; Carson DA; Beutler E N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613 [TBL] [Abstract][Full Text] [Related]
3. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index. Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609 [TBL] [Abstract][Full Text] [Related]
4. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey. Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283 [TBL] [Abstract][Full Text] [Related]
5. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review. Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814 [TBL] [Abstract][Full Text] [Related]
6. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment]. Urasiński I; Zdziarska B; Krygier-Stojałowska A Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow trephines. Findings in patients with hairy cell leukaemia before and after treatment. Pittaluga S; Verhoef G; Maes A; Boogaerts MA; De Wolf-Peeters C Histopathology; 1994 Aug; 25(2):129-35. PubMed ID: 7982675 [TBL] [Abstract][Full Text] [Related]
8. Advances in therapy for hairy cell leukemia. A review. Jaiyesimi IA; Kantarjian HM; Estey EH Cancer; 1993 Jul; 72(1):5-16. PubMed ID: 7685243 [TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical detection and quantification of minimal residual disease using DBA.44 antibodies in trephination biopsies of hairy cell leukemia]. Dĕdic K; Zák P Cesk Patol; 2003 Oct; 39(4):175-7. PubMed ID: 14663929 [TBL] [Abstract][Full Text] [Related]
11. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Estey EH; Kurzrock R; Kantarjian HM; O'Brien SM; McCredie KB; Beran M; Koller C; Keating MJ; Hirsch-Ginsberg C; Huh YO Blood; 1992 Feb; 79(4):882-7. PubMed ID: 1346577 [TBL] [Abstract][Full Text] [Related]